Evolution of Public Health Human Papillomavirus Immunization Programs in Canada
Background: Since 2007, all Canadian provinces and territories have had a publicly funded program for vaccination against human papillomavirus (HPV) infection. The objective of this study was to describe the evolution of these vaccination programs. Methods: This was a targeted literature review of p...
Published in: | Current Oncology |
---|---|
Main Authors: | , , , , , |
Format: | Text |
Language: | English |
Published: |
MDPI
2021
|
Subjects: | |
Online Access: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985769/ http://www.ncbi.nlm.nih.gov/pubmed/33617515 https://doi.org/10.3390/curroncol28010097 |
id |
ftpubmed:oai:pubmedcentral.nih.gov:7985769 |
---|---|
record_format |
openpolar |
spelling |
ftpubmed:oai:pubmedcentral.nih.gov:7985769 2023-05-15T17:22:41+02:00 Evolution of Public Health Human Papillomavirus Immunization Programs in Canada Goyette, Alexandra Yen, Glorian P. Racovitan, Voica Bhangu, Parambir Kothari, Smita Franco, Eduardo L. 2021-02-22 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985769/ http://www.ncbi.nlm.nih.gov/pubmed/33617515 https://doi.org/10.3390/curroncol28010097 en eng MDPI http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985769/ http://www.ncbi.nlm.nih.gov/pubmed/33617515 http://dx.doi.org/10.3390/curroncol28010097 © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). CC-BY Curr Oncol Article Text 2021 ftpubmed https://doi.org/10.3390/curroncol28010097 2021-03-28T01:46:59Z Background: Since 2007, all Canadian provinces and territories have had a publicly funded program for vaccination against human papillomavirus (HPV) infection. The objective of this study was to describe the evolution of these vaccination programs. Methods: This was a targeted literature review of public HPV vaccination programs and vaccination coverage rates, based on information provided by jurisdictional public health authorities. Results: HPV vaccination of schoolgirls began in school years 2007/08 to 2010/11 with three doses of the quadrivalent HPV vaccine in all provinces except Quebec, which started with two doses. By 2018/19, all jurisdictions were vaccinating with two doses of the nonavalent vaccine in both girls and boys, except Quebec, which used a mixed vaccination schedule with one dose of the nonavalent and one dose of the bivalent vaccines. Public HPV vaccination programs in most provinces include after-school catch-up vaccination. Immunocompromised or other high-risk individuals are eligible for the HPV public vaccination program in most provinces, but policies vary by jurisdiction. In 2017/18, vaccination coverage rates in provincial HPV school-based programs varied from 62% in Ontario to 86% in Prince Edward Island in girls and from 58% in Ontario to 86% in Prince Edward Island in boys. Conclusions: Since their introduction, Canadian school-based HPV public vaccination programs have evolved from a three-dose to a two-dose schedule, from a quadrivalent to a nonavalent vaccine, and from a girls-only to a gender-neutral policy. Vaccination coverage rates have varied markedly and only Prince Edward Island and Newfoundland/Labrador have maintained rates exceeding 80%. Text Newfoundland Prince Edward Island PubMed Central (PMC) Canada Newfoundland Current Oncology 28 1 991 1007 |
institution |
Open Polar |
collection |
PubMed Central (PMC) |
op_collection_id |
ftpubmed |
language |
English |
topic |
Article |
spellingShingle |
Article Goyette, Alexandra Yen, Glorian P. Racovitan, Voica Bhangu, Parambir Kothari, Smita Franco, Eduardo L. Evolution of Public Health Human Papillomavirus Immunization Programs in Canada |
topic_facet |
Article |
description |
Background: Since 2007, all Canadian provinces and territories have had a publicly funded program for vaccination against human papillomavirus (HPV) infection. The objective of this study was to describe the evolution of these vaccination programs. Methods: This was a targeted literature review of public HPV vaccination programs and vaccination coverage rates, based on information provided by jurisdictional public health authorities. Results: HPV vaccination of schoolgirls began in school years 2007/08 to 2010/11 with three doses of the quadrivalent HPV vaccine in all provinces except Quebec, which started with two doses. By 2018/19, all jurisdictions were vaccinating with two doses of the nonavalent vaccine in both girls and boys, except Quebec, which used a mixed vaccination schedule with one dose of the nonavalent and one dose of the bivalent vaccines. Public HPV vaccination programs in most provinces include after-school catch-up vaccination. Immunocompromised or other high-risk individuals are eligible for the HPV public vaccination program in most provinces, but policies vary by jurisdiction. In 2017/18, vaccination coverage rates in provincial HPV school-based programs varied from 62% in Ontario to 86% in Prince Edward Island in girls and from 58% in Ontario to 86% in Prince Edward Island in boys. Conclusions: Since their introduction, Canadian school-based HPV public vaccination programs have evolved from a three-dose to a two-dose schedule, from a quadrivalent to a nonavalent vaccine, and from a girls-only to a gender-neutral policy. Vaccination coverage rates have varied markedly and only Prince Edward Island and Newfoundland/Labrador have maintained rates exceeding 80%. |
format |
Text |
author |
Goyette, Alexandra Yen, Glorian P. Racovitan, Voica Bhangu, Parambir Kothari, Smita Franco, Eduardo L. |
author_facet |
Goyette, Alexandra Yen, Glorian P. Racovitan, Voica Bhangu, Parambir Kothari, Smita Franco, Eduardo L. |
author_sort |
Goyette, Alexandra |
title |
Evolution of Public Health Human Papillomavirus Immunization Programs in Canada |
title_short |
Evolution of Public Health Human Papillomavirus Immunization Programs in Canada |
title_full |
Evolution of Public Health Human Papillomavirus Immunization Programs in Canada |
title_fullStr |
Evolution of Public Health Human Papillomavirus Immunization Programs in Canada |
title_full_unstemmed |
Evolution of Public Health Human Papillomavirus Immunization Programs in Canada |
title_sort |
evolution of public health human papillomavirus immunization programs in canada |
publisher |
MDPI |
publishDate |
2021 |
url |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985769/ http://www.ncbi.nlm.nih.gov/pubmed/33617515 https://doi.org/10.3390/curroncol28010097 |
geographic |
Canada Newfoundland |
geographic_facet |
Canada Newfoundland |
genre |
Newfoundland Prince Edward Island |
genre_facet |
Newfoundland Prince Edward Island |
op_source |
Curr Oncol |
op_relation |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985769/ http://www.ncbi.nlm.nih.gov/pubmed/33617515 http://dx.doi.org/10.3390/curroncol28010097 |
op_rights |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
op_rightsnorm |
CC-BY |
op_doi |
https://doi.org/10.3390/curroncol28010097 |
container_title |
Current Oncology |
container_volume |
28 |
container_issue |
1 |
container_start_page |
991 |
op_container_end_page |
1007 |
_version_ |
1766109482866180096 |